Episode 147: CEP290 mRNA intravitreal therapy for LCA


Manage episode 224391075 series 1424443
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.

This week’s episode focuses on a recent publication (https://www.nature.com/articles/s41591-018-0295-0) in Nature Medicine concerning the successful use of an intravitreal oligonucleotide for a form of Leber Congential Amaurosis (LCA). First, Dr. Allen Ho, one of the authors of the paper, rejoins the program to discuss the project and its implications. Then Dr. Matthew Weed returns to offer his perspective as a ophthalmic genetics specialist on this trial compared to other modalities such as Luxturna and what it means for the future. Dr Weed and Dr. Sridhar have no relevant financial disclosures. Dr. Ho has receieved grant funding from Pro QR.

Click here to view our “Lessons from our Pupils” Blog Post related to this episode!

154 episodes available. A new episode about every 5 days averaging 30 mins duration .